Vistagen Therapeutics Inc (VTGN)
2.58
+0.05
(+1.98%)
USD |
NASDAQ |
Nov 22, 16:00
2.565
-0.02
(-0.58%)
Pre-Market: 20:00
Vistagen Therapeutics Market Cap: 71.84M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 71.84M |
| November 21, 2024 | 70.44M |
| November 20, 2024 | 72.67M |
| November 19, 2024 | 74.34M |
| November 18, 2024 | 73.79M |
| November 15, 2024 | 73.23M |
| November 14, 2024 | 76.01M |
| November 13, 2024 | 78.52M |
| November 12, 2024 | 81.58M |
| November 11, 2024 | 84.09M |
| November 08, 2024 | 87.43M |
| November 07, 2024 | 86.87M |
| November 06, 2024 | 86.31M |
| November 05, 2024 | 85.22M |
| November 04, 2024 | 87.12M |
| November 01, 2024 | 84.14M |
| October 31, 2024 | 83.33M |
| October 30, 2024 | 83.60M |
| October 29, 2024 | 82.52M |
| October 28, 2024 | 81.98M |
| October 25, 2024 | 81.44M |
| October 24, 2024 | 81.98M |
| October 23, 2024 | 81.98M |
| October 22, 2024 | 83.87M |
| October 21, 2024 | 81.17M |
| Date | Value |
|---|---|
| October 18, 2024 | 83.06M |
| October 17, 2024 | 82.79M |
| October 16, 2024 | 81.71M |
| October 15, 2024 | 79.00M |
| October 14, 2024 | 81.71M |
| October 11, 2024 | 81.98M |
| October 10, 2024 | 81.71M |
| October 09, 2024 | 79.00M |
| October 08, 2024 | 79.54M |
| October 07, 2024 | 77.65M |
| October 04, 2024 | 81.44M |
| October 03, 2024 | 79.81M |
| October 02, 2024 | 81.17M |
| October 01, 2024 | 82.79M |
| September 30, 2024 | 81.44M |
| September 27, 2024 | 83.06M |
| September 26, 2024 | 81.17M |
| September 25, 2024 | 82.79M |
| September 24, 2024 | 81.44M |
| September 23, 2024 | 81.98M |
| September 20, 2024 | 85.22M |
| September 19, 2024 | 81.17M |
| September 18, 2024 | 81.03M |
| September 17, 2024 | 83.87M |
| September 16, 2024 | 85.22M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
12.43M
Minimum
Jun 26 2023
660.66M
Maximum
Jul 01 2021
158.83M
Average
83.06M
Median
Sep 27 2024
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 3.327M |
| Palatin Technologies Inc | 18.77M |
| iBio Inc | 24.15M |
| Theriva Biologics Inc | 3.562M |
| Oragenics Inc | 3.346M |
Market Cap Related Metrics
| PS Ratio | 86.65 |
| Price to Book Value | 0.7726 |
| Price | 2.58 |
| Earnings Yield | -52.03% |